“Profile of Sales and Notifications of Suspected Adverse Events Related to Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic”. Research, Society and Development, vol. 12, no. 2, Jan. 2023, p. e15112240021, https://doi.org/10.33448/rsd-v12i2.40021.